Skip to main content
. 2022 Nov 2;57(Suppl 1):100–416. doi: 10.1038/s41409-022-01798-0
14BT057 (18) SOC (10)
Age at transplant (years), median (range) 10.6 (0.3-20.0) 8 (1.7-11.7)
Female, # (%) 6 (33) 5 (50)
Race/Ethnicity, n (%)
 White, Non-Hispanic 13 (72) 6 (60)
 African-American - 1 (10)
 Hispanic 5 (28) 1 (10)
 Middle Eastern - 2 (20)
Disease, n (%)
Severe Aplastic Anemia (SAA)
 Idiopathic 9 (50) 3 (30)
 SAA with >10% PNH 1 (6) -
 Hepatitis associated 2 (11) 4 (40)
Diamond-Blackfan Anemia 1 (6) 1 (10)
Severe Congenital Neutropenia 4 (22) 1 (10)
Congenital Sideroblastic Anemia - 1 (10)
Amegakaryocytic Thrombocytopenia 1 (6) -
Time from diagnosis to SCT (years), median (range) 0.2 (0.1 to 15) 0.2 (0.1 to 9.1)
More than 10 lifetime PRBC transfusions pre-SCT 1 (6) 2 (20)
Prior treatments n (%) 1 (6) -
IST for aplastic anemia (hATG/CSA) Steroids for hepatitis/DBA 2 (11) 4 (40)
Chronic RBC/platelet Transfusions 2 (11) 1 (10)
Chronic G-CSF 4 (22) 1 (10)